Editas Medicine Long Term Deferred Assets (Quarterly) Trends

Editas Medicine, Inc. (EDIT)

2.03 -0.06 (-2.87%) USD | NASDAQ | Jan 16, 16:00

2.06 +0.03 (+1.48%) After-Hours: 20:00

View Long Term Deferred Assets (Quarterly) for EDIT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

ADMA Biologics, Inc.	Upgrade
Arcutis Biotherapeutics, Inc.	--
Daré Bioscience, Inc.	--
Cogent Biosciences, Inc.	--
Janux Therapeutics, Inc.	--